# Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors

> **NCT01125891** · PHASE1 · COMPLETED · sponsor: **Traws Pharma, Inc.** · enrollment: 39 (actual)

## Conditions studied

- Malignant Neoplasmas
- Solid Tumors

## Interventions

- **DRUG:** gemcitabine
- **DRUG:** ON 01910.Na

## Key facts

- **NCT ID:** NCT01125891
- **Lead sponsor:** Traws Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2017-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01125891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01125891, "Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01125891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*